Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma | MicrobiomeTrials← Back to trialsNCT06014827
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
SUSPENDEDPHASE2INTERVENTIONAL
Trial Details
Start: 2024-10-09Est. Completion: 2027-03-09
Enrollment target: 32 participants Locations- City of Hope Medical Center, Duarte, California, United States
- Yale University, New Haven, Connecticut, United States
Other microbiome trials you might be interested in
Non Squamous Non Small Cell Lung Cancer
This is a randomized, multicenter, multinational, double-blind, integrated pharmacokinetics (PK) and efficacy similarity…
Yerevan, ArmeniaEst. completion Aug 31, 2026
Epidermal Growth FactorEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Gene MutationNon Small CellNon Small Cell LungNon Small Cell Lung CancerHead and Neck
Head and Neck Cancer
Head and Neck Cancers
Head and Neck Squamous Cell Cancer
Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma HNSCC
NSCLC (Non-small Cell Lung Cancer)
HNSCC
EGFR
A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of…
Los Angeles, United StatesEst. completion Jul 2029